20 Mar One for all….
The phrase “One for all and All for One” was made famous by Andre Dumas in his famous novel the three musketeers. It was used earlier by William Shakespeare in a poem to characterize people who take massive risks, including the poem’s villainous king, Tarquin the Proud:
“The aim of all is but to nurse the life
With honour, wealth, and ease, in waning age;
And in this aim there is such thwarting strife,
That one for all, or all for one we gage;
As life for honour in fell battle’s rage;
Honour for wealth; and oft that wealth doth cost
The death of all, and all together lost.”
What’s all this got to do with heart health you may ask??
Well, how is it fair that the privileged few in society get all the preventative tests like CT scans of the heart?
At the moment “Screening CT scans” for the heart are used routinely for Presidents, astronauts and fast jet pilots. Wealthy people who can pay can also access these tests. Why can’t it be done for all??
It can, modern scanning technology has brought effective x ray doses down, we have more scanners. The cost is real and the benefits are as yet unknown. The harms are those of ionising radiation and exposure to contrast as well as identifying incidental lung nodules and the like.
Lung cancer screening using CT is already in the pilot phase in the UK, it has found coronary calcium (plaque) in the majority of patients. Over half of the patients eligible for statin therapy under NICE guidance were not taking them.
Seeing may be believing in motivating people to improve lifestyle and take preventative medication, a Danish study of chest pain patients showed those who had visible plaque and knew they did were 4.5 times more likely to be taking a statin and had greater reductions in cholesterol and HbA1C ( a marker for diabetes).
Why aren’t we doing the screening then?? For a screening programme to meet criteria it should meet the Wilson Criteria.
The Wilson criteria for screening emphasise the important features of any screening program, as follows:
- the condition should be an important health problem
- the natural history of the condition should be understood
- there should be a recognisable latent or early symptomatic stage
- there should be a test that is easy to perform and interpret, acceptable, accurate, reliable, sensitive and specific
- there should be an accepted treatment recognised for the disease
- treatment should be more effective if started early
- there should be a policy on who should be treated
- diagnosis and treatment should be cost-effective
- case-finding should be a continuous process
We’re getting close. The only blockage is the medical evidence to guide the policy.
The evidence base is moving towards showing that cardiac CT screening, a “mammogram for the heart” so to speak, can improve the health of a population.
More trials may be needed in high risk populations. For example, such a trial may take 5 or 10 years to prove a benefit and need 10,000 patients, it would likely cost about ten million pounds to perform.
Until the evidence is here and/or policy changes, it seems like its all for one.

Vinoda Sharma
Posted at 11:07h, 20 MarchThanks Tom
Agree there is a need for for screening and possibly randomising patient to CTCA versus usual follow up
Thanks for generating the discussion on this topic